Trade CLDI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Calidi Biotherapeutics, Inc. (CLDI) is trading at US$1.30, up 0.08% today as of Aug 28, 10:21 EDT. The company has a market capitalisation of US$3.46M. Over the past 52 weeks, CLDI has traded between US$1.25 and US$27.84. On Syfe you can trade CLDI with $0 commission and add it to your watchlist.
| Previous close | US$1.30 |
|---|---|
| Market cap | US$3.46M |
| 52-week range | US$1.25 – US$27.84 |
| Volume | 129.28K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Year: 2023
Calidi Biotherapeutics to Effect 1-for-16 Reverse Stock Split
Jul 20, 8:58 PM · MT Newswires
Calidi Biotherapeutics Receives Positive Feedback From FDA for CLD-401 Pre-IND Application
Jun 16, 12:52 PM · MT Newswires
Calidi Biotherapeutics, Inc. (CLDI) stock is trading at US$1.30, +0.08% from the previous close of US$1.30.
The market cap for Calidi Biotherapeutics, Inc. (CLDI) stock is approximately US$3.46M.
The 52-week high for Calidi Biotherapeutics, Inc. (CLDI) stock is US$27.84.
The 52-week low for Calidi Biotherapeutics, Inc. (CLDI) stock is US$1.25.
Calidi Biotherapeutics, Inc. (CLDI) does not currently pay a dividend.
Stay on top of CLDI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
